Abstract:Objective To establish a scoring system based on the preoperative serum levels of alpha-fetoprotein（AFP） and alkaline phosphatase（ALP）, and to investigate its value in predicting the prognosis of patients with resectable hepatocellular carcinoma（HCC）. Methods A retrospective analysis was performed for 154 HCC patients who underwent hepatectomy as the initial treatment in Tianjin First Central Hospital from January 2016 to August 2019. The receiver operating characteristic（ROC） curve was used to determine the optimal cut-off values of serum AFP and ALP; the Kaplan-Meier curve and the log-rank test were used for survival analysis to evaluate the relationship between the AFP-ALP score and disease-free survival（DFS）; univariate and multivariate Cox regression analyses were used to identify the independent prognostic factors for HCC patients. The independent samples t-test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. Results The ROC curve analysis showed that serum AFP had an optimal cut-off value of 250.0 ng/mL and an area under the ROC curve（AUC） of 0.674（95% confidence interval [CI]: 0.580-0.767） in predicting DFS, while serum ALP had an optimal cut-off value of 95.5 U/L and an AUC of 0.745（95% CI: 0.652-0.838）. The survival analysis showed that high preoperative serum levels of AFP（≥250.0 ng/mL） and ALP（≥95.5 U/L） were significantly associated with the poor prognosis of HCC patients（P＜0.001）. Based on the AFP-ALP score, all HCC patients were further divided into 0-point group（AFP＜250.0 ng/mL and ALP＜95.5 U/L）, 1-point group（AFP≥250.0 ng/mL, ALP＜95.5 U/L; or AFP＜250.0 ng/mL, ALP ≥95.5 U/L）, and 2-point group（AFP≥250.0 ng/mL and ALP≥95.5 U/L）. The survival curves showed that the 0-, 1-, and 2-point groups had a median DFS of 60.0（56.7-67.3） months, 20.0（1.4-36.6） months, and 13.0（7.9-18.0） months, respectively, and there were significant survival differences between the three groups（P＜0.05）. Serum AFP-ALP score（1 point vs 0 point: hazard ratio [HR]=4.060, 95% confidence interval [CI]: 2.050-8.039, P＜0.001; 2 points vs 0 point: HR=4.583, 95%CI: 2.385-8.805, P＜0.001） was an independent prognostic factor for HCC patients. Conclusion The scoring system based on the serum levels of AFP and ALP can effectively identify HCC patients with poor prognosis, and therefore, it might be used as a simple and reliable tool for prognostic assessment in the clinical treatment of HCC.

Elevated Afp, Atv, And Afp/Atv Ratios As Risk Factors For Poor Prognosis Of Hcc Patients In The Bclc-A Stage

Daily Decrease of Post-Operative Alpha-Fetoprotein by 9% Discriminates Prognosis of HCC: A Multicenter Retrospective Study.

Preoperative Neutrophil-to-lymphocyte Ratio is an Independent Prognostic Predictor for AFP Negative Hepatocellular Carcinoma after Hepatectomy

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma

The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study

Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy.

Prognostic value of preoperative absolute lymphocyte count in recurrent hepatocellular carcinoma following thermal ablation: a retrospective analysis.

Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma

Prognostic Value of Serum Α‐fetoprotein Level As an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis

A Case-Control Study of Correlation Between Preoperative Serum Afp and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy

Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma

Correlation Between Preoperative Serum Alpha-Fetoprotein (AFP) Level and Early Recurrence of Patients with Hepatocellular Carcinoma after Partial Hepatectomy

Combining Γ‐gt , PIVKA‐II , and AFP to Predict Long‐term Prognosis in Patients with Hepatocellular Carcinoma after Hepatectomy

Alpha Fetoprotein Changes Predict Hepatocellular Carcinoma Survival Beyond the Milan Criteria after Hepatectomy.

Value of a Scoring System Based on the Serum Levels of Alpha-Fetoprotein and Alkaline Phosphatase in Predic-Ting the Prognosis of Patients with Resectable Hepatocellular Carcinoma

Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.

Predictive Effects of Preoperative Serum CA125 and AFP Levels on Post-Hepatectomy Survival in Patients with Hepatitis B-related Hepatocellular Carcinoma

Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization

Preoperative Prognostic Value of Alfa-Fetoprotein Density in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation